欧美精品在线第一页,久久av影院,午夜视频在线播放一三,久久91精品久久久久久秒播,成人一区三区,久久综合狠狠综合久久狠狠色综合,成人av一区二区亚洲精,欧美a级在线观看
 
Scientists develop a two-step approach to starve lung tumor cells
                 Source: Xinhua | 2018-04-03 04:39:00 | Editor: huaxia

These two lung samples are from mice prone to develop Kras-mutant non-small-cell lung cancer. The lungs of mouse on the left are filled with tumors, as expected. The lung on the right, whose Kras-mutant cells have lost the Irs1/Irs2 genes, lacks the insulin/IGF-1 signaling needed for growth and is virtually devoid of tumors. (In a later stage, the tumors develop a workaround that enables them to start growing again.) (Credit: Clare (He) Xu, PhD, Boston Children's Hospital)

WASHINGTON, April 2 (Xinhua) -- American scientists developed a two-prolonged therapy with a combination of drugs that are already available clinically to starve the tumor cells to death.

The Boston Children's Hospital study, published on Monday in the Proceedings of the National Academy of Sciences, has shown that the non-small-cell lung cancer driven by an oncogene called KRAS can be treated after completely blocking IFG-1 signaling.

IGF-1 signaling is a pathway that influences the uptake and release of nutrients and ultimately cell growth, according to the researchers.

"Growth factors like IGF-1 tell cells that nutrients are around, so when you suppress their signaling, the tumor cells don't take up the amino acids," said Nada Kalaany, a researcher in Boston Children's Hospital and the paper's senior author.

Kalaany's team used two groups of mice with KRAS-driven lung cancer. The second group has been deleted with two key genes, known as Irs1 and Irs2, which encode so-called "adaptor" proteins that are necessary for insulin/IGF-1 signaling.

"Almost all animals in this lung cancer model typically die within 15 weeks of KRAS activation," said Kalaany. "But the ones that lost both Irs1 and Irs2 were completely fine, we saw almost no tumors at 10 to 15 weeks."

Metabolic profiling revealed that tumor cells lacking Irs1/2 had significantly lower levels of essential amino acids, the building blocks of protein. Yet, outside the cells, amino acids were plentiful.

But that's not the whole story. When tumor cells "think" that they are starved, according to Kalaany, they can compensate for this and break down their own proteins to generate amino acids.

The researchers tried to inhibit the protein breakdown with existing drugs, such as chloroquine, which inhibits autophagy, and bortezomib, a proteasome inhibitor that is used to treat multiple myeloma.

When Kalaany's team injected human tumor cells lacking Irs1/2 into mice, tumors didn't grow as well. When they added inhibitors of protein breakdown, growth was almost completely suppressed.

"Our work tries to identify metabolic dependencies and vulnerabilities in tumors," said Kalaany.

However, Kalaany warned that, though both types of drugs, as well as IGF-1 inhibitors, are well tolerated, care would need to be taken in dosing any combination therapy to avoid toxicities.

Back to Top Close
Xinhuanet

Scientists develop a two-step approach to starve lung tumor cells

Source: Xinhua 2018-04-03 04:39:00

These two lung samples are from mice prone to develop Kras-mutant non-small-cell lung cancer. The lungs of mouse on the left are filled with tumors, as expected. The lung on the right, whose Kras-mutant cells have lost the Irs1/Irs2 genes, lacks the insulin/IGF-1 signaling needed for growth and is virtually devoid of tumors. (In a later stage, the tumors develop a workaround that enables them to start growing again.) (Credit: Clare (He) Xu, PhD, Boston Children's Hospital)

WASHINGTON, April 2 (Xinhua) -- American scientists developed a two-prolonged therapy with a combination of drugs that are already available clinically to starve the tumor cells to death.

The Boston Children's Hospital study, published on Monday in the Proceedings of the National Academy of Sciences, has shown that the non-small-cell lung cancer driven by an oncogene called KRAS can be treated after completely blocking IFG-1 signaling.

IGF-1 signaling is a pathway that influences the uptake and release of nutrients and ultimately cell growth, according to the researchers.

"Growth factors like IGF-1 tell cells that nutrients are around, so when you suppress their signaling, the tumor cells don't take up the amino acids," said Nada Kalaany, a researcher in Boston Children's Hospital and the paper's senior author.

Kalaany's team used two groups of mice with KRAS-driven lung cancer. The second group has been deleted with two key genes, known as Irs1 and Irs2, which encode so-called "adaptor" proteins that are necessary for insulin/IGF-1 signaling.

"Almost all animals in this lung cancer model typically die within 15 weeks of KRAS activation," said Kalaany. "But the ones that lost both Irs1 and Irs2 were completely fine, we saw almost no tumors at 10 to 15 weeks."

Metabolic profiling revealed that tumor cells lacking Irs1/2 had significantly lower levels of essential amino acids, the building blocks of protein. Yet, outside the cells, amino acids were plentiful.

But that's not the whole story. When tumor cells "think" that they are starved, according to Kalaany, they can compensate for this and break down their own proteins to generate amino acids.

The researchers tried to inhibit the protein breakdown with existing drugs, such as chloroquine, which inhibits autophagy, and bortezomib, a proteasome inhibitor that is used to treat multiple myeloma.

When Kalaany's team injected human tumor cells lacking Irs1/2 into mice, tumors didn't grow as well. When they added inhibitors of protein breakdown, growth was almost completely suppressed.

"Our work tries to identify metabolic dependencies and vulnerabilities in tumors," said Kalaany.

However, Kalaany warned that, though both types of drugs, as well as IGF-1 inhibitors, are well tolerated, care would need to be taken in dosing any combination therapy to avoid toxicities.

010020070750000000000000011105091370837361
主站蜘蛛池模板: 国产精华一区二区精华| 欧美在线视频一二三区| 久久久久久久亚洲视频| 欧美一区二区三区爽大粗免费| 亚洲自拍偷拍一区二区三区| 国产老妇av| 精品videossexfreeohdbbw| 欧美日韩卡一卡二| 国产精品日韩三级| 处破大全欧美破苞二十三| 国产精品天堂网| 精品国产乱码久久久久久老虎| 亚洲欧洲一二三区| 国产欧美精品久久| 欧美亚洲视频一区| 日韩一区二区三区福利视频| 精品国产1区2区3区| 亚洲欧美色图在线| 在线精品国产一区二区三区88| 国产原创一区二区| 欧美国产在线看 | 日本免费电影一区二区三区| 国产69精品久久99不卡解锁版| 日本一区二区三区电影免费观看| 国产精品综合一区二区三区| 视频一区二区三区欧美| 中文字幕精品一区二区三区在线| 91精品一区二区在线观看| 国产精品videossex国产高清| 欧洲精品一区二区三区久久| 天堂av一区二区三区| 亚洲欧美日韩三区| 国内精品国产三级国产99| 欧美片一区二区| 国产精品偷乱一区二区三区| 中文无码热在线视频| 狠狠色噜噜狠狠狠狠2021免费| 91制服诱惑| 5g影院天天爽入口入口| 亚洲精品性| 午夜影皖精品av在线播放| 午夜天堂在线| 久久黄色精品视频| 国产精品九九九九九九九 | 国产精品亚洲精品一区二区三区| 日韩一级在线视频| 国产91精品一区二区麻豆亚洲| 日本五十熟hd丰满| 粉嫩久久99精品久久久久久夜| 亚洲第一天堂无码专区 | 亚洲**毛茸茸| 欧美在线视频一区二区三区| 一本色道久久综合亚洲精品图片| 日日夜夜亚洲精品| 91久久精品在线| 精品少妇一区二区三区免费观看焕| 午夜影院h| 亚洲欧美制服丝腿| 欧美日韩卡一卡二| 国产人成看黄久久久久久久久| 色吊丝av中文字幕| 午夜色影院| 欧美日韩国产123| 国偷自产一区二区三区在线观看 | 999久久久国产| 日本边做饭边被躁bd在线看| 麻豆精品一区二区三区在线观看| 国产精品久久久久久久久久久久冷| 午夜影院你懂的| 欧美精品五区| 狠狠干一区| 欧美在线视频三区| 国产精品一区二区毛茸茸| 久久午夜鲁丝片| 日韩中文字幕区一区有砖一区| 91人人爽人人爽人人精88v| www色视频岛国| 国产精品亚洲а∨天堂123bt| 国产91精品高清一区二区三区| 香蕉av一区| 国产中文字幕一区二区三区| 91avpro|